BEST MEDICINES FOR OUR BEST FRIENDS
Thanks to this strategy, we will avoid the typical 5% to 10% success rate seen with new chemical entities in traditional drug development: our goal is to achieve 50% to 70% success rate.
In addition, we develop our therapeutics for an average of approximately $5 to $8 million in only 5 to 6 years. Typical veterinary drugs reach peak sales between $10 million and $100 million per year. The market for veterinary drugs may only be one tenth the size of the human market, but the development cost of veterinary drugs is about one hundred times cheaper. In other words, our return on investment is very attractive.
We are a pioneer in animal biotechnology. We have an industry-leading scientific team and a robust pipeline.
1 American Pet Products Association. [Access Date: January 29, 2018]. Available from: http://www.americanpetproducts.org/press_industrytrends.asp